UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children

Stroke (1970), 2000-06, Vol.31 (6), p.1283-1288

2000

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of using recombinant factor VIIa in continuous infusion

Thrombosis and haemostasis, 1996, Vol.75 (3), p.432

1996

Link zum Volltext

Verfügbarkeit prüfen

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A

British journal of haematology, 1992-12, Vol.82 (4), p.729-734

1992

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience

Thrombosis and haemostasis, 1994-09, Vol.72 (3), p.403

1994

Link zum Volltext

Verfügbarkeit prüfen

Why Demography Matters (excerpt)

Ėkonomicheskaia sot͡s︡iologii͡a, 2022, Vol.23 (2), p.36-64

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

Blood coagulation & fibrinolysis, 2000-04, Vol.11 Suppl 1, p.S35-S38

2000

Link zum Volltext

Verfügbarkeit prüfen

Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune‐mediated clearance of von Willebrand factor

British journal of haematology, 1997-01, Vol.96 (1), p.179-182

1997

Link zum Volltext

Verfügbarkeit prüfen

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment

Arteriosclerosis, thrombosis, and vascular biology, 1999-03, Vol.19 (3), p.511

1999

Link zum Volltext

Verfügbarkeit prüfen

Warfarin: From Bedside to Bench

The New England journal of medicine, 1984-09, Vol.311 (10), p.645-652

1984

Link zum Volltext

Verfügbarkeit prüfen

Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy

Ophthalmology (Rochester, Minn.), 1999-04, Vol.106 (4), p.739-742

1999

Link zum Volltext

Verfügbarkeit prüfen

Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor

Thrombosis and haemostasis, 1993, Vol.70 (3), p.522

1993

Link zum Volltext

Verfügbarkeit prüfen

Lack of Correlation Between Activated Clotting Time and Plasma Heparin During Cardiopulmonary Bypass

Annals of surgery, 1981-01, Vol.193 (1), p.105-111

1981

Link zum Volltext

Verfügbarkeit prüfen

Dental extraction for patients on oral anticoagulant therapy

Oral surgery, oral medicine, oral pathology, 1990-09, Vol.70 (3), p.274-277

1990

Link zum Volltext

Verfügbarkeit prüfen

Increased cardiovascular disease mortality rates in traumatic lower limb amputees

The American journal of cardiology, 1998-11, Vol.82 (10), p.1242-1247

1998

Link zum Volltext

Verfügbarkeit prüfen

Dose-Dependent Antithrombotic Effect of Warfarin in Rabbits

Blood, 1983-03, Vol.61 (3), p.435-438

1983

Link zum Volltext

Verfügbarkeit prüfen

Risk factors associated with postpartum ovarian vein thrombosis

Thrombosis and haemostasis, 1999-09, Vol.82 (3), p.1015

1999

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of heparin and warfarin

Journal of the American College of Cardiology, 1986-12, Vol.8 (6), p.10B-20B

1986

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma

The Journal of biological chemistry, 1984-06, Vol.259 (11), p.6890-6895

1984

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease

Thrombosis and haemostasis, 1999-02, Vol.81 (2), p.229

1999

Link zum Volltext

Verfügbarkeit prüfen

A Polypeptide Region of Bovine Prothrombin Specific for Binding to Phospholipids

Proceedings of the National Academy of Sciences - PNAS, 1973-05, Vol.70 (5), p.1344-1348

1973

Link zum Volltext

Verfügbarkeit prüfen

Thrombosis: the relationship of hemostatic mechanisms to drug therapy

Journal of neurosurgery, 1981-01, Vol.54 (1), p.1

1981

Link zum Volltext

Verfügbarkeit prüfen

Preparation and Identification of a Population of Antibodies That Recognize Carbodiimide-Modified Heparin

Blood, 1985-04, Vol.65 (4), p.902-911

1985

Link zum Volltext

Verfügbarkeit prüfen

Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C

Blood, 1999-08, Vol.94 (3), p.895-901

1999

Link zum Volltext

Verfügbarkeit prüfen

Heparin: New Concepts Relevant to Clinical Use

Blood, 1979-04, Vol.53 (4), p.525-544

1979

Link zum Volltext

Verfügbarkeit prüfen

The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis

Journal of bone and joint surgery. American volume, 1979-07, Vol.61 (5), p.653

1979

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Terapevtic̆eskii Arhiv
(17)
Problemy Ėndokrinologii
(9)
Blood
(7)
Klinicheskaia Meditsina
(7)
Thrombosis And Haemostasis
(7)
Kardiologiia
(6)
Hirurgija
(4)
Klinicheskaia Laboratornaia Diagnostika
(4)
Laboratornoe Delo
(4)
Sovetskaia Meditsina
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children

Feasibility of using recombinant factor VIIa in continuous infusion

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A

Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience

Why Demography Matters (excerpt)

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune‐mediated clearance of von Willebrand factor

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment

Warfarin: From Bedside to Bench

Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy

Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor

Lack of Correlation Between Activated Clotting Time and Plasma Heparin During Cardiopulmonary Bypass

Dental extraction for patients on oral anticoagulant therapy

Increased cardiovascular disease mortality rates in traumatic lower limb amputees

Dose-Dependent Antithrombotic Effect of Warfarin in Rabbits

Risk factors associated with postpartum ovarian vein thrombosis

Pharmacology of heparin and warfarin

Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma

Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease

A Polypeptide Region of Bovine Prothrombin Specific for Binding to Phospholipids

Thrombosis: the relationship of hemostatic mechanisms to drug therapy

Preparation and Identification of a Population of Antibodies That Recognize Carbodiimide-Modified Heparin

Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C

Heparin: New Concepts Relevant to Clinical Use

The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis

Suchergebnisse filtern